ABSTRACT Objective:To evaluate the safety and efficacy of montelukast combined with conrentional therapy treated Henoch Schnlein purpura children with kidney damage. Methods:Sixty seven children with Henoch Schnlein purpura were randomly divided into observation group(35 patients) and control group(32 patients). The observation group received montelukast combined with conventional therapy,the control group received only conventional therapy. Followed up the efficacy for 2 months, the change of serum CysC, serum β2-MG, urine TRF, urine mAlb and urine β2-MG were observed, and the curative effect was compared. Results:The curative effect of the observation group was 94.3%, which was higher than control group’s 75.0%(P<0.05). The serum CysC, serum β2-MG, urine TRF, urine mAlb and urine β2-MG of two groups were decreased significantly than before(P<0.05);in addition to the blood levels of CysC between the two groups had no statistical significance (P>0.05), other indicators level in observation group were significantly lower than the control group(P<0.05).Conclusion:Montelukast combined with conventional therapy could improve the efficacy significantly, and lower the incidence rate of Henoch schnlein purpura nephritis. |